Other Genomes In Our Body Flashcards

1
Q

What is a meta genome

A

It is the genetic material in the environment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is a microbiota

A

It’s the community of organisms

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is a micro biome

A

It is the collective genomes of microorganisms in an environment as well as their proteins and metabolites

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are the two metagenomic approaches

A

Targeted PCR amplification
This targets a single gene marker to identify variations between species e.g. 16s rRNA or 18s rRNA

Whole genome SHOTGUN sequencing

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Why 16S rRNA PCR

A

16S = component of the 30S prokaryotic ribosome

Largely conserved with variable regions different between genus and species

The conserved regions allow primer design

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Describe the use of the 16S variable regions

A

9 variable regions, combinations include:
V1-2, V1-3, V3-4, V4-5, V1-9

You choose the combination according to the regions that are different enough to differentiate species common in the tissue/environment of investigation

Smaller regions = better as NGS short reads are more likely to overlap (2*300bp)

Long read can be used but these have high error rates

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are the drawbacks of 16S targeted PCR amplification

A

It is sensitive to contamination as it can pick up bacteria on the environment, operator, reagent. This effect is larger when biomass is smaller

Biased to bacteria

It is not reliable below genus, and requires suitable choice of variable region

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

How can you mitigate contamination in 16S Targeted PCR amplification

A

Randomise samples - test controls and cases at same time

Note batch number of reagents - use same batch

Sequence negative controls - this effectively sequences any contamination on the reagents or tools

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is whole genome SHOTGUN sequencing

A

Sample > extract > sequence WITHOUT PCR > analyse

You can either reassemble genomes or simply bin reads into specifies to find out what the species are

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What are the pros and cons of whole genome shotgun sequencing

A

There is no bias to a single organism

However host cells are often in excess and can overpower (depends on tissue e.g. faecal = <10%, while skin = >90% human cells)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

How can you overcome whole genome shotgun limitations

A

Pre extraction = differential lysis of mammalian cells

This is biased to gram +ve bacteria as they have thick cell walls that can resist lysis

Post extraction = enzymatic degredation of methylated DNA (mammalian methylation pattern is different)

This is biased to AT rich bacterial genomes, with GC rich being weakest

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Compare 16S targeted PCR amplification and whole genome shotgun sequencing

A

16S = taxonomic diversity BUT only bacteria and PCR introduces bias

WGSS = taxonomic diversity and gene function determined, and unbiased to species UNLESS enriched. Has high throughput for low cost

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is dysbiosis

A

This is when the microbiota changes which could be due to new eating habits or antibiotics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Why is the microbiome important

A

It is integral to host digestion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is autochthonous and allochthonous bacteria

A
Autochthonous = resident
Allochthonous = passenger
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What are the benefits of a diverse microbiome

A

Increased energy and nutrient extraction via provision of unique enzymes e.g. to digest fibre

Alteration of appetitive signals

The competition of good V bad pathogen is protective to host

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What can the microbiome tell you

A

It can identify if someone is lean or obese with 90% accuracy

Associated with IBD, depression, cancer etc. and allergic reactions e.g. asthma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Describe the role of the microbiome in IBS/IBD

A

Altering the microbiota through dietary changes, probiotics or antibiotics can be beneficial

The gut brain access can alter symptom perception in the brain

Whether IBS does not have a single cause so some patients benefit but it can be used as a diagnostic tool

IBD is inflammation in the gut - with environmental and genetic risk factors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

How is the microbiome changed in colorectal cancer

A

Higher proportion of pseudomonas, heliobacter, acinetobacter

Less beneficial bacteria such as butyrate producing bacteria and bifidobacterium

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

What are some interventions to correct the gut microbiota

A

Prebiotic - consumption of undigestable food to increase beneficial bacterial growth

Probiotic - increased beneficial bacteria, FMT is a probiotic

Symbiotic - mix of the above

HOWEVER THERE IS NOT MUCH EVIDENCE

Lactobacillus and bifidobacteria is the most common beneficial bacteria

21
Q

How does clostridium difficile infection affect the miccrobiome

A

The microbiome is very different and has a greater effect than host genetics

Individuals are most susceptible if the microbiota diversity is low

22
Q

What bacteria does FMT increase/decrease after clostridium difficile infection

A

Increases firmicutes and bacteroides

Decreases proteobacteria

23
Q

Describe the role of dysbiosis in psychiatric disorders

A

It increases translocation of gut bacteria into lymphoid tissue, provoking immune response, and activation of the vagus nerve and spinal afferent neurons

It is associated with autism, depression etc.

24
Q

What is bacterial vaginosis

A

BV = increased discharge

Often asymptotic with risk of STI and can cause preterm birth

25
Q

How is the microbiome changed in Bacterial Vaginosis

A

BV = overgrowth of anaerobic bacteria, gardnerella vaginalis

Healthy = lactobacillus

26
Q

What kind of environment is the skin and how does this relate to its microbiome

A

It is a nutrient poor acidic environment where the microbiota remain stable overtime

Sebaceous sites - propionibacterium
Moist - staph and cornyebacterium

27
Q

What diseases are associated with skin microbiome dysbiosis

A

Cutaneous disease such as acne, a topic dermatitis, psoriasis

28
Q

What is the importance of the oral microbiome

A

It’s contained oral homoeostasis and protects the oral cavity and prevents disease development

It can be affected by smoking, alcohol, spicy food, antibiotics

29
Q

What diseases are associated with oral microbiome dysbiosis

A

Because associated with dental caries, periodontal diseases and systemic diseases as well as cancer

Systemic diseases include cardiovascular disease, pneumonia, rheumatoid arthritis

Cancers include pancreatic, colorectal, oesophageal cancer

30
Q

What is a rare disease

A

With disease that affects less than 1 in 2000 individuals

31
Q

List systems where mitochondrial gene mutations may have a large impact

A

Brain, heart, muscle, guts

It can be multisystem or isolated

It can start at any age and have a wide disease spectrum

32
Q

List how drugs can influence mitochondrial disease - in nuclear and mitochondrial DNA

A

Epilepsy treatment valproate can cause fatal hepatopathy in POLG disease (nuclear gene)

Mitochondrial DNA mutations predisposing to aminoglycosides induced deafness (mitochondrial DNA)

33
Q

Describe sodium valproate (VPA) and POLG VPA toxicity

A

VPA is used to treat epilepsy as a first-line therapy but is also used for migraines, headaches, and bipolar disorder

POLG mutations predispose to VPA toxicity
Rare mutations in POLG, which codes for the mitochondrial DNA polymerase γ (polγ), cause the Alpers-Huttenlocher syndrome (AHS)

Polymerase gamma is the mitochondrial DNA polymerase that is most commonly mutated in mitochondrial disease
Backlight toxicity can induce fatal liver failure

34
Q

What is aminoglycoside induced ototoxicity

A

A1555G predisposed to aminoglycoside induced ototoxicity

It is the most common genetic predisposition to aminoglycosides induced deafness (33-59%)

35
Q

What are aminoglycosides and give some examples of them

A

These are antibiotics including streptomycin, kanamycin, neomycin

These are used in the treatment of gram-negative sepsis

They are bactericidal, targeting the bacterial ribosome, where they bind to the A-site and disrupt protein synthesis

36
Q

What are some examples of side-effects of aminoglycosides

A

Side-effects include ototoxicity and nephrotoxicity

These occur due to similarity of bacterial and mitochondria ribosomes as these drugs can bind each other

37
Q

Describe the mechanism of action of chloramphenicol/macrolides and lincosamides

A

These bind the 50S ribosome subunit

They prevent peptide bond formation and stop protein synthesis

It is important to note that resistance can rise when there are mutations in the rRNA

38
Q

Describe the antibiotic mechanism of action of tetracyclines

A

These bind to 30S ribosomal subunit

They blocked the binding of tRNA thus inhibit protein synthesis

It is important to note that mutations in the 30S ribosomal subunit may cause resistance

39
Q

Describe the mechanism of action of aminoglycosides

A

They bind to the 30S ribosomal subunit

They impair proofreading resulting in production of faulty protein which misfold and aggregate which is toxic

40
Q

Are there any cure for mitochondrial diseases

A

No treatments are largely supportive and only treat the symptoms

As they can cause toxicity in patients with specific gene mutation there are no approved therapies yet

41
Q

What symptoms or secondary consequence of generic therapies for mitochondrial disorders target

A

They can target oxidative stress and eliminate reactive oxygen species
There may be drugs that increase the number of mitochondria who overcome problems (mitochondrial biogenesis)

42
Q

Why are some mitochondrial disease clinical trials not successful

A

This is because there are few patients with the same mutations in the same gene

Heterogeneous phenotypes that fluctuate over time

They may be poor trial design and inappropriate endpoints

43
Q

What targeted therapies for genetic diseases could be considered for mitochondrial disease

A

Enzyme replacement therapy
Dietary therapy for inborn errors of metabolism
Stem cell therapy

Gene therapy
You cannot just insert new gene
CRISPR guide RNA cannot enter mitochondria
Therefore TALENS or zinc finger nucleases are used which target disease mtDNA so healthy mtDNA replicate

Mitochondrial replacement therapy a.k.a. three parent babies

Mutation specific therapy

44
Q

List some mitochondrial mutation specific therapies

A

Treating premature stop codons (10% inherited)

Therapy for splicing mutations - antisense oligonucleotide therapy

Therapies for missense mutations causing protein misfolding - pharmacological chaperone

45
Q

What are TALENS and Zinc finger nucleases

A

Zinc finger and TALENs are

Proteins with a DNA cutting region and a DNA grabbing region

It can be programmed to recognise different genes

TALEN is easier to design than zinc finger

46
Q

Describe why premature stop codons are bad, and the therapies for premature stop codon treatment

A

Normally the ribosome proceeds to the stop codon before dissociating and releasing the protein
Premature stop codon = early release = smaller protein and might result in nonsense mediated decay

The therapy allows the ribosome to bypass premature termination cover and continue to synthesise a full length protein

These drugs are not specific for any particular protein so it can be effective for many stop codon mutations

47
Q

Describe therapies for splicing mutations

A

Antisense oligonucleotide therapy targets splicing

It has been approved in Duchenne’s muscular dystrophy and spinal muscular atrophy

48
Q

Describe therapies for missense mutations causing protein misfolding

A

Pharmacological chaperone find specific protein helping it fold and retains its activity

It is currently used in lysosomal storage disease and cystic fibrosis

Mutation is MRPL44 courses protein this folding an infantile onset of cardiomyopathy

49
Q

What does the mutation in MRPL44 cause

A

It causes protein misfolding and infantile onset cardiomyopathy